Benzinga | Jul 23, 2020 08:56AM EDT

Mizuho Maintains Neutral on Neurocrine Biosciences, Raises Price Target to $127

Mizuho maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Neutral and raises the price target from $105 to $127.